Comparative study between Bleomycin sclerotherapy and interstitial Nd:YAG laser in treatment of venous malformations

Mena Gerges Boktor;

Abstract


Venous malformation (VM) is the most common form of
vascular malformation, which affects approximately 1% of the
population. VM affects different anatomic regions of the body and
different types of tissues, with variable presenting symptoms including
swelling/contour deformity, skin discolouration and pain. Aim of the
Work: to compare effectiveness of bleomycin sclerotherapy and
Nd:YAG interstitial laser in the treatment of venous malformation by
using subjective clinical assessment and objective changes on MR
imaging. Patients and Methods: This study was done at plastic
surgery department in Ain Shams University hospitals between June
2015 to June 2018. It included 30 patients of all age groups of both sex,
with venous malformation. Results: Considering outcome, in our study
(73.3%) of group I showed Significant outcome while (0%) of group II
showed significant outcome with mild to moderate outcome mainly
occurred in group II. Conclusion: Level of satisfaction and
improvement are better in patients treated by bleomycin sclerotherapy than
of patients treated by Nd: YAG interstitial laser. Also bleomycin
sclerotherapy is safer especially in pediatrics and in head and neck lesions,
cheaper and occur as outpatient procedure. There was statistically
significant relation between overall outcome according to Size and level of
satisfaction.


Other data

Title Comparative study between Bleomycin sclerotherapy and interstitial Nd:YAG laser in treatment of venous malformations
Other Titles دراسة مقارنة بين البلوميسين كمعالج للتصليب وليزر النيوديميوم الخلالي في علاج التشوهات الوريدية
Authors Mena Gerges Boktor
Issue Date 2019

Attached Files

File SizeFormat
cc3335.pdf585.59 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 13 in Shams Scholar
downloads 13 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.